Status: Recruiting
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters
The study aims to evaluate and confirm the performance of 047 TD Dermatitis cream in the improvement of eczematous dermatitis and contact dermatitis, throughout a reduction in disease severity and symptoms.
Participants needed: 90
Trial details
Age: 6-65Biological sex: AllType: InterventionalSponsor: Biokosmes SrlUpdated: Jul 9, 2025Locations: 3
Eligibility criteria
Male/ female > 6 months < 65 years [+4]
Hypersensitivity to any 047_TD Dermatitis cream ingredients [+7]